Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕Edelweiss Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundEdelweiss Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaEdelweiss
NAV₹591.2429₹9.2021
NAV date20 Nov 202620 Nov 2026
History20.6 years2.3 years
Expense ratio1.8%2.7%
Stars★★★★★Not rated
Growth Score78.10—

Returns

Nippon India Pharma FundEdelweiss Business Cycle Fund
1 month+11.32%+5.71%
3 months+3.52%+0.80%
6 months+8.09%+4.95%
YTD+16.05%+1.69%
1 year+14.27%+2.20%
3 years (CAGR)+16.91%—
5 years (CAGR)+14.37%—
10 years (CAGR)+15.58%—
Since launch+17.64%−3.74%

Risk

Nippon India Pharma FundEdelweiss Business Cycle Fund
Volatility14.1%—
Downside volatility9.1%—
Sharpe0.74—
Sortino1.15—
Calmar1.14—
Return / risk1.20—
Deepest fall−47.36%−26.91%
Days to recover301—
Below its high+0.00%−10.68%

Against benchmark

Nippon India Pharma FundEdelweiss Business Cycle Fund
Alpha−2.75%—
Beta0.89—
R²89.5%—
Up capture83.5%—
Down capture91.2%—
Tracking error4.8%—
Information ratio−0.88—
Treynor0.11—

Consistency

Nippon India Pharma FundEdelweiss Business Cycle Fund
Best 1-year+175.79%+19.06%
Middle 1-year+13.84%−0.57%
Worst 1-year−36.67%−16.02%
1-year periods with a loss23.4%51.7%
Middle 3-year+20.93%—
Positive months63.9%—
Best day+3.40%+4.77%
Worst day−3.21%−3.86%
Worst 5% day−1.38%−2.02%
Positive days53.7%53.1%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundEdelweiss Business Cycle Fund
5-year XIRR+17.18%—
5-year value₹9,29,284—
3-year XIRR+13.26%—
1-year XIRR+21.05%+7.48%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth